The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
In recent years it has become apparent through the use of ER agonists and antagonists that the biological actions of estrogens are multifaceted. Estrogens and antiestrogens mediate their effects through diverse molecular mechanisms. Thus, SERMs can be viewed as a class of compounds that exhibit an expanse of estrogen actions and specificity that capitalize on the preexistence of multiple cellular pathways of ER action in different target tissues. It is anticipated that the continued use of in vitro and animal models will reveal additional mechanisms of ER signaling and tissue response and provide a more clear understanding of the spectrum of estrogen action, which will facilitate the development of novel pharmaceuticals for the treatment of estrogen-associated pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous system
Shughrue, P. J., Lane, M. V., & Merchenthaler, I. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971201)388:4<507::aid-cne1>3.0.co;2-6 · Cited by 2,259
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Self-citationNuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,113
Cited by
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Melanin pigmentation in mammalian skin and its hormonal regulation
Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00044.2003 · Cited by 2,015
Estrogen receptors: how do they signal and what are their targets
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857
Wang, Z.-Y., Nakano, T., Gendron, J., He, J., Chen, M., Vafeados, D., Yang, Y., Fujioka, S., Yoshida, S., Asami, T., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00153-3 · Cited by 1,144
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Virtual and biomolecular screening converge on a selective agonist for GPR30
Bologa, C. G., Revankar, C. M., Young, S. M., Edwards, B. S., Arterburn, J. B., Kiselyov, A. S., Parker, M. A., Tkachenko, S. E., Savchuck, N. P., Sklar, L. A., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio775 · Cited by 818
Sex Hormones in Acquired Immunity and Autoimmune Disease
Moulton, V. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02279 · Cited by 620
Estrogen Signaling Multiple Pathways to Impact Gene Transcription
Marino, M., Galluzzo, P., & Ascenzi, P. (2006) · Current Genomics · doi:10.2174/138920206779315737 · Cited by 619
Etiology and pathogenesis of uterine leiomyomas: a review.
Flake, G. P., Andersen, J., & Dixon, D. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5787 · Cited by 583
Nongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561
“In vitro studies suggest that both receptors may play redundant roles in estrogen signaling; however, tissue localization studies indicate different expression patterns for each receptor (198).”
BackgroundMueller, S. O. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh147 · Cited by 547
Estrogen Regulation of Growth Hormone Action
Leung, K.-C., Johannsson, G., Leong, G. M., & Ho, K. K. Y. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0035 · Cited by 542
Estrogen Signaling and Cardiovascular Disease
Murphy, E. (2011) · Circulation Research · doi:10.1161/circresaha.110.236687 · Cited by 497
Oestrogen as a neuroprotective hormone
Behl, C. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn846 · Cited by 488
Molecular mechanism of estrogen–estrogen receptor signaling
Yaşar, P., Ayaz, G., User, S. D., Güpür, G., & Muyan, M. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12006 · Cited by 482
Regulation of fish gonadotropins
Yaron, Z., Gur, G., Melamed, P., Rosenfeld, H., Elizur, A., & Levavi-Sivan, B. (2003) · International Review of Cytology · doi:10.1016/s0074-7696(05)25004-0 · Cited by 445
Physiology and Molecular Biology of Stress Tolerance in Plants
(2006) · Springer eBooks · doi:10.1007/1-4020-4225-6 · Cited by 418
Mårtensson, U. E. A., Salehi, S. A., Windahl, S., Gomez, M. F., Swärd, K., Daszkiewicz-Nilsson, J., Wendt, A., Andersson, N., Hellstrand, P., Grände, P.-O., et al. (2009) · Endocrinology · doi:10.1210/en.2008-0623 · Cited by 413
Menuet, A., Pellegrini, E., Anglade, I., Blaise, O., Laudet, V., Kah, O., & Pakdel, F. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.6.1881 · Cited by 413
Downstream nuclear events in brassinosteroid signalling
Vert, G., & Chory, J. (2006) · Nature · doi:10.1038/nature04681 · Cited by 404
Albanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., Oprea, T. I., Prossnitz, E. R., Musti, A. M., Andò, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2909 · Cited by 399
Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways
Alonso-Magdalena, P., Ropero, A. B., Soriano, S., García-Arévalo, M., Ripoll, C., Fuentes, E., Quesada, I., & Nadal, Á. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.012 · Cited by 358
Phytoestrogens: Recent Developments
(2003) · Planta Medica · doi:10.1055/s-2003-41122 · Cited by 339
Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations
Molina, R., Barak, V., van Dalen, A., Duffy, M. J., Einarsson, R., Gion, M., Goike, H., Lamerz, R., Nap, M., Sölétormos, G., et al. (2005) · Tumor Biology · doi:10.1159/000089260 · Cited by 334
Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R., & Safe, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1843-1855.2003 · Cited by 325
GPR30: A G protein-coupled receptor for estrogen
Prossnitz, E. R., Arterburn, J. B., & Sklar, L. A. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.010 · Cited by 310
Estrogen Receptor β: An Overview and Update
Zhao, C., Dahlman-Wright, K., & Gustafsson, J.-Å. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06003 · Cited by 309
Eeckhoute, J., Carroll, J. S., Geistlinger, T. R., Torres-Arzayus, M. I., & Brown, M. (2006) · Genes & Development · doi:10.1101/gad.1446006 · Cited by 304
Harrington, W. R., Sheng, S., Barnett, D. H., Petz, L. N., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00255-7 · Cited by 300
Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity
Turgeon, J. L., McDonnell, D. P., Martin, K. A., & Wise, P. M. (2004) · Science · doi:10.1126/science.1096725 · Cited by 297
Coregulators in Nuclear Estrogen Receptor Action: From Concept to Therapeutic Targeting
Hall, J. M. (2005) · Molecular Interventions · doi:10.1124/mi.5.6.7 · Cited by 295
Self-citationHall, J. M., & Korach, K. S. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0438 · Cited by 293
Self-citationDevelopment of cDNA microarray for expression profiling of estrogen-responsive genes
Inoue, A., Yoshida, N., Omoto, Y., Oguchi, S., Yamori, T., Kiyama, R., & Hayashi, S. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290175 · Cited by 292
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
Rochette-Egly, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00115-8 · Cited by 291
Discovery of farnesoid X receptor and its role in bile acid metabolism
Chiang, J. Y. L., & Ferrell, J. M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111618 · Cited by 288
Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance
Lewis, J. S., & Jordan, V. C. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.02.028 · Cited by 281
Sex differences and the neurobiology of affective disorders
Rubinow, D. R., & Schmidt, P. J. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0148-z · Cited by 280
Kousteni, S., Li, H., Chen, J., Almeida, M., Plotkin, L. I., Bellido, T., & Manolagas, S. C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17261 · Cited by 270
Lu, Q., Pallas, D. C., Surks, H. K., Baur, W. E., Mendelsohn, M. E., & Karas, R. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407492101 · Cited by 266
Chen, J.-Q., Cammarata, P. R., Baines, C. P., & Yager, J. D. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.06.001 · Cited by 264
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Endoplasmic Reticulum Stress and Homeostasis in Reproductive Physiology and Pathology
Guzel, E., Arlier, S., Guzeloglu-Kayisli, O., Tabak, M., Ekiz, T., Semerci, N., Larsen, K., Schatz, F., Lockwood, C., & Kayisli, U. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040792 · Cited by 257
Nontranscriptional Regulation of Cardiac Repolarization Currents by Testosterone
Bai, C.-X., Kurokawa, J., Tamagawa, M., Nakaya, H., & Furukawa, T. (2005) · Circulation · doi:10.1161/circulationaha.104.523217 · Cited by 254
Hall, J. M. (2002) · Molecular Endocrinology · doi:10.1210/me.16.3.469 · Cited by 253
Self-citationDevelopment of selective androgen receptor modulators (SARMs)
Narayanan, R., Coss, C. C., & Dalton, J. T. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.013 · Cited by 251
“Expert Opinion in Therapeutic Patents 15(11), 1565-1585.”
Bhardwaj, P., Au, C. C., Benito-Martin, A., Ladumor, H., Oshchepkova, S., Moges, R., & Brown, K. A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.002 · Cited by 233
“In ERE-dependent genomic activation, estrogen binding to its receptor is associated with increased interaction with coactivator proteins in order to bind to the ERE in DNA, resulting in changes in gene expression that regulate growth, differentiation, apoptosis and angiogenesis [80].”
BackgroundGender differences in kidney function
Sabolić, I., Asif, A. R., Budach, W. E., Wanke, C., Bahn, A., & Burckhardt, G. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0308-1 · Cited by 226
“It is generally assumed that the actions of sex hormones in their target tissues are crucially dependent on the presence of high-affinity, low-capacity sex-hormone-specific receptor proteins, which can reside in the cell membrane, cytoplasm, and/or nucleus of target cells and, after binding the respective hormone, cau…”
BackgroundPhyto-oestrogens and breast cancer chemoprevention
Limer, J. L., & Speirs, V. (2004) · Breast Cancer Research · doi:10.1186/bcr781 · Cited by 223
“The association between receptor dimers and DNA response elements is enhanced by the binding of cofactor proteins, such as amplified in breast cancer-1, thyroid hormone receptor-associated protein, SRC-1, glutamate receptor interacting protein-1 and translation initiation factor-2 [55].”
BackgroundThe Estrogen Receptors: An Overview from Different Perspectives
Eyster, K. M. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3127-9_1 · Cited by 222
Stossi, F., Barnett, D. H., Frasor, J., Komm, B., Lyttle, C. R., & Katzenellenbogen, B. S. (2004) · Endocrinology · doi:10.1210/en.2003-1682 · Cited by 219
Hou, Y., Zhang, S., Wang, L., Li, J., Qu, G., He, J., Rong, H., Ji, H., & Liu, S. (2012) · Gene · doi:10.1016/j.gene.2012.09.060 · Cited by 210
“There are also ERE-independent pathway and cell membrane signaling pathway (Hall et al., 2001).”
BackgroundThe Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System
Menazza, S., & Murphy, E. (2016) · Circulation Research · doi:10.1161/circresaha.115.305376 · Cited by 210
Rapid Estrogen Signaling in the Brain
Raz, L., Khan, M. M., Mahesh, V. B., Vadlamudi, R. K., & Brann, D. W. (2008) · Neurosignals · doi:10.1159/000111559 · Cited by 201
“A search in PubMed with the keywords ‘estrogen and nongenomic’ yields over 334 published papers, with 94p of these papers being published within the last 10 years. Thus, this area has seen an explosion of interest in the past decade, and represents one of the fastest emerging areas in the field of estrogen research. I…”
BackgroundWang, C., Mayer, J. A., Mazumdar, A., Fertuck, K., Kim, H., Brown, M., & Brown, P. H. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1037 · Cited by 194
Naciff, J. M. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.1.184 · Cited by 184
Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection
Prokai, L., Prokai-Tatrai, K., Perjesi, P., Zharikova, A. D., Perez, E. J., Liu, R., & Simpkins, J. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2032621100 · Cited by 176
Watson, C., Long, J. S., Orange, C., Tannahill, C. L., Mallon, E., McGlynn, L. M., Pyne, S., Pyne, N. J., & Edwards, J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100220 · Cited by 172
“The ER is a member of the steroid receptor family and is activated by estrogen (E2), which induces nuclear translocation, allowing the ER to function as a transcription factor to increase cell proliferation and decrease cell apoptosis.(1,2) ER-positive breast cancers are therefore”
BackgroundNalbandian, G., & Kovats, S. (2005) · Immunologic Research · doi:10.1385/ir:31:2:091 · Cited by 171
Liu, S.-B., Zhang, N., Guo, Y.-Y., Zhao, R., Shi, T.-Y., Feng, S.-F., Wang, S.-Q., Yang, Q., Li, X.-Q., Wu, Y.-M., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5828-11.2012 · Cited by 160
“Once activated, these receptors translocate to the nucleus where they function as ligand-dependent transcription factors (Hall et al., 2001).”
BackgroundComparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction
Russo, D. P., Zorn, K. M., Clark, A. M., Zhu, H., & Ekins, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00546 · Cited by 152
“Estrogen receptors (ERs) are cellular proteins that trigger the expression of gene products crucial to the endocrine system 1 .”
BackgroundHrabovszky, E., Kalló, I., Steinhauser, A., Merchenthaler, I., Coen, C. W., Petersen, S. L., & Liposits, Z. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20127 · Cited by 118
Gibson, D. A., & Saunders, P. T. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.026 · Cited by 107
Segner, H., Verburg-van Kemenade, B. M. L., & Chadzinska, M. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.07.004 · Cited by 86
Sánchez-Andrade, G., & Kendrick, K. M. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.10.016 · Cited by 72
“The problem is made more complex since estrogens have a variety of genomic and nongenomic actions (Hall et al., 2001; Toran-Allerand et al., 1999; Wise et al., 2001) and there are issues as to whether dynamic changes in physiological concentrations are important or just overall basal ones (Dohanich, 2002).”
BackgroundWang, C., Uray, I. P., Mazumdar, A., Mayer, J. A., & Brown, P. H. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1925-0 · Cited by 59
van de Stolpe, A., Slycke, A. J., Reinders, M. O., Zomer, A. W. M., Goodenough, S., Behl, C., Seasholtz, A. F., & van der Saag, P. T. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0446 · Cited by 49
Milanesi, L., Vasconsuelo, A., de Boland, A. R., & Boland, R. (2009) · Steroids · doi:10.1016/j.steroids.2009.01.005 · Cited by 47
CAPER, a novel regulator of human breast cancer progression
Mercier, I., Gonzales, D. M., Quann, K., Pestell, T. G., Molchansky, A., Sotgia, F., Hulit, J., Gandara, R., Wang, C., Pestell, R. G., et al. (2014) · Cell Cycle · doi:10.4161/cc.28156 · Cited by 45
“Ligand-occupied ERs then directly interact with DNA at the estrogen response element (ERE) to activate or repress the transcription of target genes.(9,10) Approximately 60–70% of human breast cancer cases express ERα and depend on estrogen for their growth.”
BackgroundChen, J., Liu, L., Hou, R., Shao, Z., Wu, Y., Chen, X., & Zhou, L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.04.022 · Cited by 42
“As previously described in detail, 17b-estradiol (E2) is involved in regulating a number of physiological processes in ER-positivebreast cancer cells, includingproliferation, invasiveness, and changes in cytoarchitecture [15], Therefore E2 was used as a positive control in this study.”
MethodBonthuis, P. J., Patteson, J. K., & Rissman, E. F. (2011) · Endocrinology · doi:10.1210/en.2010-1001 · Cited by 37
Jiang, W., Cheung, R. Y. K., Chung, C. Y., Chan, S. S. C., & Choy, K. W. (2024) · Genes · doi:10.3390/genes16010005 · Cited by 9
“Estrogen regulates the transcriptional signature of its target tissues via the nuclear pathway activated by binding to ER-α and ER-β [77].”
Metadata
- Authors
- Hall, J. M., Couse, J. F., & Korach, K. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 276
- Issue
- 40
- Pages
- 36869-36872
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2093676604
- Cited by
- 1,208
- References
- 57
- FWCI
- 29.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.